Brain Ischemia Market 2018 | Major Leading Players H. Lundbeck A/S, Vernalis Plc, Hitachi Ltd., Penumbra, Inc., ThromboGenics NV, Bayer AG |Future Outlook 2023

Global Brain Ischemia Market Research Report, by Diagnosis (MRI, CT, ultrasound, angiography and other), by Treatment (angioplasty, drug treatment and other), by End User (hospital, clinics and other)- Forecast Till 2023 

The global brain ischemia market is expected to grow at a CAGR of 6.5% during forecasted period 2017-2023.

KEY PLAYERS FOR GLOBAL BRAIN ISCHEMIA MARKET

Bayer AG (Germany), H. Lundbeck A/S (Denmark), Bristol-Myers Squibb Company (US), Boehringer Ingelheim GmbH (Germany), ThromboGenics NV (Belgium), Vernalis Plc (UK), Neurotec Pharma SL (Spain), Johnson and Johnson (US), Covidien Plc (Ireland), Stryker Corporation (US), Abbott Laboratories (US), Penumbra, Inc. (US), Philips Healthcare (Netherland), Hitachi Ltd. (Japan), GE Healthcare (UK) and  Siemens Healthcare (US).

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1424 .

MARKET SCENARIO FOR GLOBAL BRAIN ISCHEMIA MARKET

Brain ischemia is a condition in which there is an insufficient blood flow to the brain which results in poor oxygen supply to the brain. Brain ischemia is also known as cerebral ischemia or cerebrovascular ischemia. Major driving factor for global brain ischemia market are increasing number of patient suffering from diabetes, obesity hypertension and other related diseases as well as increasing aging population. On other hand high cost of treatment and limited availability of effective drugs may be responsible for restraining the market’s growth

SEGMENTATION FOR GLOBAL BRAIN ISCHEMIA MARKET

Global brain ischemia market is segmented on the basis of diagnosis which are segmented into MRI, CT, ultrasound, angiography and other. On the basis of treatment the market is segmented into angioplasty, drug treatment and other. Drug treatment is further sub segmented into anticoagulation therapy, antiplatelet and other. Anticoagulation therapy is further sub segmented as heparin and warfarin and antiplatelet therapy is further sub segmented into aspirin and other. On the basis of end user the market is segmented into hospital, clinics and other.

REGIONAL ANALYSIS FOR GLOBAL BRAIN ISCHEMIA MARKET

On regional basis, North America has the largest market of brain ischemia.  Due to the increasing diabetic and obese population in this region, these have become a major driving factor for this market’s growth. Moreover increasing government’s support has also lead to the growth of this market. Europe is the second largest market due to increasing aging population and technological advances here. Emerging economies like India and China in Asia-Pacific region has provided to be a fuel for the growth of this market here.  Middle East and Africa contributes less to this market’s growth.

Get Discount @ https://www.marketresearchfuture.com/check-discount/1424 .

MAJOR TOC FOR GLOBAL BRAIN ISCHEMIA MARKET

CHAPTER 1. INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

CHAPTER 2. RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH

CHAPTER 3. MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

CHAPTER 4. MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

CHAPTER 5. GLOBAL BRAIN ISCHEMIA MARKET, BY DIAGNOSIS

5.1 MRI

5.2 CT

5.3 ULTRASOUND

5.4 ANGIOGRAPHY

5.5 OTHER

Ask to Expert Inquire @ https://www.marketresearchfuture.com/enquiry/1424 .

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future, Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune - 411028 Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.